Campathecin structure
|
Common Name | Campathecin | ||
---|---|---|---|---|
CAS Number | 7689-03-4 | Molecular Weight | 348.352 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 757.0±60.0 °C at 760 mmHg | |
Molecular Formula | C20H16N2O4 | Melting Point | 260 °C (dec.)(lit.) | |
MSDS | Chinese USA | Flash Point | 411.6±32.9 °C | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of CampathecinCampathecin is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM. |
Name | camptothecin |
---|---|
Synonym | More Synonyms |
Description | Campathecin is a potent DNA enzyme topoisomerase I inhibitor, with an IC50 of 679 nM. |
---|---|
Related Catalog | |
Target |
Topoisomerase I:679 nM (IC50) |
In Vitro | [3H]BrCPT labeling of topoisomerase I is enhanced greatly by the presence of DNA; very little labeling of isolated topoisomerase I or isolated DNA occurrs. Even in the presence of DNA, [3H]BrCPT labeling of topoisomerase I is inhibited by camptothecin, suggesting that both CPT and BrCPT bind to the same site on the DNA-topoisomerase I binary complex[1]. With increasing concentrations of camptothecin, closed circular pRR322 DNA (form I) is converted to nicked circular DNA (form 11). This apparent nicking activitv of camptothecin required DNA topoisomerase I[2]. |
Kinase Assay | Each reaction mixture (200 μL, total volume) contained 2 μg of supercoiled pDPT2789 DNA (2.4 nM plasmid concentration), 50 mM Tris-HCl, pH 7.5, 120 mM KCl, 10 mM MgCl2, 0.5 mM EDTA, 0.05% dimethyl sulfoxide, 1% methanol, 100 μg/mL BSA, 4.3 ng of calf thymus topoisomerase I (0.26 nM), and a CPT derivative. The reaction mixture is incubated at 37°C, and at the indicated times 20-μL aliquots are removed and terminated by the addition of 5 μL of SDS/Ficoll stop mix (final concentrations, 0.5% SDS, 2% Ficoll, 0.025% bromphenol blue). The samples are loaded onto a 1% agarose gel and analyzed by electrophoresis. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 757.0±60.0 °C at 760 mmHg |
Melting Point | 260 °C (dec.)(lit.) |
Molecular Formula | C20H16N2O4 |
Molecular Weight | 348.352 |
Flash Point | 411.6±32.9 °C |
Exact Mass | 348.110992 |
PSA | 81.42000 |
LogP | 1.60 |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.746 |
Water Solubility | insoluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | Missing Phrase - N15.00950417 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic; |
Risk Phrases | R25 |
Safety Phrases | S45-S36/37/39-S26 |
RIDADR | UN 1544 6.1/PG 3 |
WGK Germany | 3 |
RTECS | UQ0492000 |
Precursor 6 | |
---|---|
DownStream 9 | |
TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity.
Oncotarget 5(18) , 8107-22, (2014) p53 plays a key role in regulating DNA damage response by suppressing cell cycle progression or inducing apoptosis depending on extent of DNA damage. However, it is not clear why mild genotoxic stress... |
|
DNA damage-specific deubiquitination regulates Rad18 functions to suppress mutagenesis.
J. Cell Biol. 206(2) , 183-97, (2014) Deoxyribonucleic acid (DNA) lesions encountered during replication are often bypassed using DNA damage tolerance (DDT) pathways to avoid prolonged fork stalling and allow for completion of DNA replica... |
|
A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells.
Eur. J. Pharm. Sci. 63 , 87-95, (2014) The PI3K/Akt/mTOR/S6 ribosomal protein signalling pathway is a key potential target in breast cancer therapy, playing a central role in proliferation and cell survival. In this study, we found that th... |
EINECS 444-280-6 |
Camptothecin |
d-Camptothecin |
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)- |
(S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
(S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione |
CaMpathecin |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)- |
(S)-(+)-Camptothecin |
(4S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)- |
Camptohecin |
MFCD00081076 |
Baicalin std. |
CAMPTOTHECINE |
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)- |
(S)-4-ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizinol[1,2-b]quinoline-3,14(4H,12H)-dione |
(+)-Camptothecin |
(+)-Camptothecine |